Literature DB >> 20107032

IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.

L Naumann, E Feist, A Natusch, S Langen, A Krause, F Buttgereit, G-R Burmester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20107032     DOI： 10.1136/ard.2009.108068

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  32 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

Review 2.  [Adult onset Still's disease, fever, diagnosis and therapy].

Authors:  N T Baerlecken; R E Schmidt
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

3.  Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases.

Authors:  Xiao-Dan Kong; Dong Xu; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2010-06-14       Impact factor: 2.980

Review 4.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 5.  Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts--from the point of view of mouse genomics.

Authors:  Yanhong Cao; Yan Jiao; Lishi Wang; Yue Huang; Arnold Postlethwaite; John Stuart; Andy Kang; Robert W Williams; Weikuan Gu
Journal:  Int Immunopharmacol       Date:  2012-03-14       Impact factor: 4.932

Review 6.  Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Authors:  Ryota Sakai; Hayato Nagasawa; Eiko Nishi; Ayumi Okuyama; Hirofumi Takei; Takahiko Kurasawa; Tsuneo Kondo; Koji Nishimura; Yuichiro Shirai; Tatsuya Ito; Hideto Kameda; Tsutomu Takeuchi; Koichi Amano
Journal:  Clin Rheumatol       Date:  2012-01-04       Impact factor: 2.980

7.  Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still's disease.

Authors:  Sanjaya K Satapathy; M Isabel Fiel; Juan Del Rio Martin; Costica Aloman; Thomas D Schiano
Journal:  Hepatol Int       Date:  2010-10-24       Impact factor: 6.047

8.  May anakinra be used earlier in adult onset Still disease?

Authors:  Guillaume Moulis; Laurent Sailler; Leonardo Astudillo; Gregory Pugnet; Philippe Arlet
Journal:  Clin Rheumatol       Date:  2010-04-30       Impact factor: 2.980

9.  Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).

Authors:  C M Hedrich; N Bruck; B Fiebig; M Gahr
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 10.  Targeting inflammasomes in rheumatic diseases.

Authors:  Alexander So; Annette Ives; Leo A B Joosten; Nathalie Busso
Journal:  Nat Rev Rheumatol       Date:  2013-05-14       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.